Addressing these regulatory challenges requires a multifaceted approach. Streamlining the approval processes for clinical trials and drugs without compromising safety is essential. Enhancing collaboration between regulatory bodies and healthcare providers can lead to more efficient regulatory frameworks. Additionally, advocating for insurance reforms to ensure equitable coverage for gynecological services is crucial for improving patient care.
